SCHEMBL805276

SCHEMBL805276

COCCOCC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2603682 0.97 CES2 (0.50)
SCHEMBL29994373 0.97 CES2 (0.50)
SCHEMBL18467823 0.97 CES2 (0.50)
SCHEMBL18467759 0.97 CES2 (0.50)
SCHEMBL18467770 0.97 CES2 (0.50)
SCHEMBL11065093 0.89 CES2 (0.61)
SCHEMBL10938191 0.88 CES2 (0.42)
SCHEMBL24936046 0.86 CES2 (0.55)
SCHEMBL22198415 0.86 CES2 (0.58)
SCHEMBL20932195 0.86 CES2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820869-B2 Method for depolymerising oxygenated polymer materials by nucleophilic catalysis COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2023-11-21 US disclosed
US-11793881-B2 Polyethylene glycol conjugate medicament, preparation method therefor and use thereof Chongqing Upgra Biotechnology Co., Ltd. (CN) 2023-10-24 US disclosed
US-20230303769-A1 Method for Preparing Polyether Amine Catalyst, and Polyether Amine Zhejiang Huangma Shangyi New Material Co., Ltd. (CN) 2023-09-28 US disclosed
US-11759460-B2 Method of local antibiotic treatment of infective endocarditis DEVIE MEDICAL GMBH (DE) 2023-09-19 US disclosed
US-20180147289-A9 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2018-05-31 US disclosed
US-20170349587-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG SHIONOGI & CO., LTD. (JP) 2017-12-07 US disclosed
US-20170333567-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2017-11-23 US disclosed
US-9808011-B2 Pentacyclic triterpene compounds and uses thereof BIOVECTRA INC. (CA) 2017-11-07 US disclosed
US-20170298001-A1 TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF CORSAIR PHARMA INC (US) 2017-10-19 US disclosed
US-20170266308-A1 SMALL MOLECULE CONJUGATES SPECIFICALLY ACTIVATED IN TUMOR MICROENVIROMENT FOR TARGETING AND USE THEREOF YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECHNOLOGY CO. LTD. (CN) 2017-09-21 US disclosed
WO-2007058989-A2 QUINAZOLINES USEFUL AS MODULATORS OF VOLTAGE GATED ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-05-24 WO disclosed
US-20070112043-A1 Acylated and non-acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides, and uses thereof AEGERA THERAPEUTICS, INC. (CA) 2007-05-17 US disclosed
US-20070060616-A1 Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds SIGNAL PHARMACEUTICALS, LLC 2007-03-15 US disclosed
US-20070050018-A1 Biodegradable stents WAINWRIGHT JOHN 2007-03-01 US disclosed
US-20070050018-A1 Biodegradable stents WAINWRIGHT JOHN 2007-03-01 US disclosed
US-20070032513-A1 Quinazoline derivatives ASTRAZENECA AB (SE) 2007-02-08 US disclosed
CN-1278185-C Positive photoresist composition and method for forming etch resistant pattern TOKYO APPLIED CHEMICAL INDUSTR (JP) 2006-10-04 CN disclosed
WO-2005120515-A2 NOVEL SULFONAMIDES AS INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2005-12-22 WO disclosed
WO-2005061450-A2 HIV PROTEASE INHIBITING SULFONAMIDES ABBOTT LABORATORIES (US) 2005-07-07 WO disclosed
CN-1469199-A Positive photoresist composition and method for forming etch resistant pattern 东京应化工业株式会社 2004-01-21 CN disclosed